Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk.

Beachler DC, Gellert LL, Jacobson LP, Ambinder RF, Breen EC, Martínez-Maza O, Rabkin CS, Kaslow RA, D'Souza G.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):188-92. doi: 10.1097/QAI.0b013e3181ff976b. Erratum in: J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e103. Rabkin, Charles C [corrected to Rabkin, Charles S].

2.

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V.

Blood. 2002 Apr 1;99(7):2331-6.

4.

Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda.

Engels EA, Mbulaiteye SM, Othieno E, Gomez M, Mathew S, Cesarman E, Knowles DM, Chadburn A.

Hum Pathol. 2007 Feb;38(2):308-14. Epub 2006 Nov 13.

PMID:
17097130
5.

Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.

Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E.

Blood. 1997 Aug 1;90(3):1186-91.

6.

No increased human herpesvirus 8 seroprevalence in patients with HIV-associated non-Hodgkin's lymphoma.

Gérard L, Agbalika F, Sheldon J, Maillard A, Schulz TF, Oksenhendler E.

J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):182-4.

PMID:
11242187
7.

Population-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among Ugandans.

Shebl FM, Emmanuel B, Bunts L, Biryahwaho B, Kiruthu C, Huang ML, Pfeiffer RM, Casper C, Mbulaiteye SM.

J Med Virol. 2013 Sep;85(9):1602-10. doi: 10.1002/jmv.23613.

8.

Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.

Nishiwaki M, Fujimuro M, Teishikata Y, Inoue H, Sasajima H, Nakaso K, Nakashima K, Sadanari H, Yamamoto T, Fujiwara Y, Ogawa N, Yokosawa H.

J Med Virol. 2006 Dec;78(12):1635-42.

PMID:
17063511
9.

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?

Lazzi S, Bellan C, Amato T, Palummo N, Cardone C, D'Amuri A, De Luca F, Beyanga M, Facchetti F, Tosi P, Leoncini L.

Hum Pathol. 2006 Jan;37(1):23-31.

PMID:
16360412
10.

HHV-8 and multiple myeloma in France.

Marcelin AG, Dupin N, Bouscary D, Bossi P, Cacoub P, Ravaud P, Calvez V.

Lancet. 1997 Oct 18;350(9085):1144. No abstract available.

PMID:
9343508
11.

Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases.

Quintanilla-Martínez L, Lome-Maldonado C, Ott G, Gschwendtner A, Gredler E, Reyes E, Angeles-Angeles A, Fend F.

Blood. 1997 Jan 15;89(2):644-51.

12.

Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.

Kabyemera R, Masalu N, Rambau P, Kamugisha E, Kidenya B, De Rossi A, Petrara MR, Mwizamuholya D.

BMC Pediatr. 2013 Jan 7;13:4. doi: 10.1186/1471-2431-13-4.

13.

Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection.

Campbell TB, Fitzpatrick L, MaWhinney S, Zhang X, Schooley RT.

J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):333-40.

PMID:
10634194
14.

Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.

Labo N, Miley W, Benson CA, Campbell TB, Whitby D.

AIDS. 2015 Jun 19;29(10):1217-25. doi: 10.1097/QAD.0000000000000682.

PMID:
26035321
15.

Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.

Fu B, Sun F, Li B, Yang L, Zeng Y, Sun X, Xu F, Rayner S, Guadalupe M, Gao SJ, Wang L.

J Med Virol. 2009 Aug;81(8):1422-31. doi: 10.1002/jmv.21550.

16.

Continuous exposure to Kaposi sarcoma-associated herpesvirus (KSHV) in healthcare workers does not result in KSHV infection.

Mancuso R, Brambilla L, Boneschi V, Hernis A, Agostini S, Tourlaki A, Bellinvia M, Clerici M.

J Hosp Infect. 2013 Sep;85(1):66-8. doi: 10.1016/j.jhin.2013.06.007. Epub 2013 Aug 2.

PMID:
23916891
17.

Kaposi's sarcoma-associated herpesvirus (KSHV) infection: endemic strains and cladograms from immunodeficient patients in China.

Zhu B, Chen Y, Xie Y, Wu N, Shendu J, Wang Y.

J Clin Virol. 2008 May;42(1):7-12. doi: 10.1016/j.jcv.2007.11.018. Epub 2008 Feb 27.

PMID:
18164650
18.

Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.

Pinzone MR, Berretta M, Cacopardo B, Nunnari G.

Semin Oncol. 2015 Apr;42(2):258-71. doi: 10.1053/j.seminoncol.2014.12.026. Epub 2014 Dec 31. Review.

PMID:
25843730
19.

Prevalence of Kaposi sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District, Uganda.

Wawer MJ, Eng SM, Serwadda D, Sewankambo NK, Kiwanuka N, Li C, Gray RH.

Sex Transm Dis. 2001 Feb;28(2):77-81.

PMID:
11234789
20.

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM.

N Engl J Med. 1995 May 4;332(18):1186-91.

Supplemental Content

Support Center